Variant report
Variant | nsv519599 |
---|---|
Chromosome Location | chr5:120686298-120703917 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr5:120684041..120685887-chr5:120689318..120691883,2 | K562 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FTMT-3 | chr5:120698697-120701009 | NONHSAT103459 |
2 | lnc-FTMT-2 | chr5:120692501-120693093 | ENSG00000229855.4 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs6865013 | chr5:120686298-120686299 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs377736320 | chr5:120686303-120686304 | Active TSS Enhancers Flanking Active TSS | n/a | n/a | Overlapped CNVs | n/a |
3 | rs556374017 | chr5:120686417-120686418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs529619859 | chr5:120686465-120686466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs574748500 | chr5:120686472-120686473 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs542170471 | chr5:120686483-120686484 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs10065954 | chr5:120686486-120686487 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs10073882 | chr5:120686518-120686519 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs76595452 | chr5:120686536-120686537 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs564333805 | chr5:120686546-120686547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs532080898 | chr5:120686551-120686552 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs191642671 | chr5:120686591-120686592 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73277919 | chr5:120686600-120686601 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs558771746 | chr5:120690814-120690815 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs577181958 | chr5:120690818-120690819 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs10478512 | chr5:120690843-120690844 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs75969052 | chr5:120690852-120690853 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs372498172 | chr5:120690853-120690854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs542057739 | chr5:120690922-120690923 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs375518238 | chr5:120690957-120690958 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs560310053 | chr5:120690965-120690966 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs527832265 | chr5:120690967-120690968 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs116008440 | chr5:120691000-120691001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs571092168 | chr5:120691097-120691098 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs532034037 | chr5:120691107-120691108 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs10463740 | chr5:120691130-120691131 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs139969457 | chr5:120691206-120691207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs143605064 | chr5:120691249-120691250 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146778868 | chr5:120691344-120691345 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs116317764 | chr5:120691358-120691359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs114953367 | chr5:120691359-120691360 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs558598977 | chr5:120691382-120691383 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs199887161 | chr5:120691396-120691397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs200981397 | chr5:120691397-120691398 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs143176550 | chr5:120691400-120691401 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs577043012 | chr5:120691424-120691425 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs17457980 | chr5:120691450-120691451 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs80187357 | chr5:120691495-120691496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs192459999 | chr5:120691506-120691507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs17458039 | chr5:120691525-120691526 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
41 | rs184433260 | chr5:120691544-120691545 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs139623382 | chr5:120691561-120691562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs572321628 | chr5:120691573-120691574 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs114068502 | chr5:120691641-120691642 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs564655370 | chr5:120691698-120691699 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs144247637 | chr5:120691703-120691704 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs113219592 | chr5:120691710-120691711 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550348821 | chr5:120691712-120691713 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs193255783 | chr5:120691724-120691725 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs529668485 | chr5:120691733-120691734 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Colorectal cancer | 16272173 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Renal cell carcinoma | 19377443 | CNVD |
Prostate cancer | 16461572 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Glaucoma | 21310917 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Gastrointestinal stromal cancer | 19259404 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:120686000-120686400 | Active TSS | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr5:120686000-120686400 | Enhancers | Dnd41 | blood |
3 | chr5:120686000-120686400 | Flanking Active TSS | NHDF-Ad | bronchial |
4 | chr5:120686200-120686600 | Enhancers | Muscle Satellite Cultured Cells | -- |
5 | chr5:120690800-120691600 | Enhancers | Fetal Lung | lung |
6 | chr5:120691600-120692600 | Weak transcription | Fetal Lung | lung |
7 | chr5:120692600-120692800 | Enhancers | Fetal Lung | lung |
8 | chr5:120693400-120694200 | Enhancers | A549 | lung |
9 | chr5:120694200-120695400 | Flanking Active TSS | A549 | lung |
10 | chr5:120701800-120702400 | Enhancers | HMEC | breast |
11 | chr5:120701800-120702600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr5:120701800-120702800 | Enhancers | Muscle Satellite Cultured Cells | -- |
13 | chr5:120702000-120702400 | Enhancers | A549 | lung |
14 | chr5:120702000-120702400 | Enhancers | Hela-S3 | cervix |
15 | chr5:120702000-120702800 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
16 | chr5:120702200-120702600 | Enhancers | NHDF-Ad | bronchial |